Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

ENT & Allergy Associates Expands Team of ENT Specialists in Forest Hills with Addition of Erick Yuen, MD

August 25, 2026

Redodo Announces “Go Light” Slogan and Lightweight Power Solutions to Simplify Outdoor Adventures

August 25, 2026

Allsteel Elevates Office Materiality with Zero-Waste Knit Innovation

August 25, 2026

LBMC Expands HITRUST Services with Authorized Reseller Status, Giving Clients One Point of Coordination for Certification

August 25, 2026

HdL Companies Welcomes Scott Hardwick, Expanding Deep Municipal and Economic Development Expertise

August 25, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Lumin Health Appoints Matthew Mosquera, MD, MS, as Regional Medical Director and Site Director of Lumin Cambridge
Press Release

Lumin Health Appoints Matthew Mosquera, MD, MS, as Regional Medical Director and Site Director of Lumin Cambridge

By News RoomApril 7, 20262 Mins Read
Lumin Health Appoints Matthew Mosquera, MD, MS, as Regional Medical Director and Site Director of Lumin Cambridge
Share
Facebook Twitter LinkedIn Pinterest Email

BOSTON, April 07, 2026 (GLOBE NEWSWIRE) — Lumin Health, a physician-led provider of interventional behavioral health care offering SPRAVATO® (esketamine) nasal spray and ketamine-based therapies in a purpose-built outpatient setting, today announced the appointment of Matthew Mosquera, MD, MS, as Regional Medical Director and Site Director of Lumin Health Cambridge, where he leads the team serving patients across Cambridge and Greater Boston.

In his role, Dr. Mosquera will oversee clinical quality and consistency across Lumin Health’s Massachusetts clinics, with a focus on standardized protocols, clinician support, and coordination with referring providers. At Lumin Health’s Cambridge location, he will focus on building a patient-centered care environment designed for people navigating treatment-resistant depression and complex mood disorders.

As demand for ketamine and esketamine treatment has grown, care has often gravitated toward hospital-based settings or at-home models. Lumin Health is designed to provide clear clinical structure and monitoring while preserving patient agency and prioritizing human support at critical moments.

“People often arrive at Lumin Health worn down by years of trying to get better and losing confidence that anything will truly change,” said Dr. Mosquera. “We take that seriously. Our role is to restore trust and optimism through rigorous care that still feels human. We pair strong screening and supervision with a calm environment and real-time support.”

Dr. Mosquera is a Harvard-trained psychiatrist, double board-certified in general and addiction psychiatry, an attending psychiatrist at McLean Hospital, and faculty at Harvard Medical School. He previously served as a medical director at McLean Hospital and has published on physician well-being and the stress of medical training.

He earned his MD from Northwestern University Feinberg School of Medicine and a master’s degree in complementary and alternative medicine from Georgetown University, which informs his whole-person approach that integrates evidence-based psychiatry with mindfulness and breathwork.

About Lumin Health
Lumin Health is a physician-led provider of interventional behavioral health care, delivering medically supervised SPRAVATO® and ketamine-based treatment in a purpose-built outpatient setting and partnering with community providers to expand responsible access to effective care.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/cb31fc23-dea3-476e-971b-6265973b0739

            
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

ENT & Allergy Associates Expands Team of ENT Specialists in Forest Hills with Addition of Erick Yuen, MD

Redodo Announces “Go Light” Slogan and Lightweight Power Solutions to Simplify Outdoor Adventures

Allsteel Elevates Office Materiality with Zero-Waste Knit Innovation

LBMC Expands HITRUST Services with Authorized Reseller Status, Giving Clients One Point of Coordination for Certification

HdL Companies Welcomes Scott Hardwick, Expanding Deep Municipal and Economic Development Expertise

Palmetto Publishing Releases Dr. Robert W. Schultz's New Leadership Guide Success 101

Five Reasons to Buy a Home on Kiawah Island

Marine Electric Vehicle Market, Till 2035: Distribution by Type of Vehicle, Type of Technology, Type of Vessel Size, Type of Range, and Geographical Regions: Industry Trends and Global Forecasts

York University School of Continuing Studies launches new Certificate in AI Governance to prepare professionals for emerging AI oversight responsibilities

Editors Picks

Redodo Announces “Go Light” Slogan and Lightweight Power Solutions to Simplify Outdoor Adventures

August 25, 2026

Allsteel Elevates Office Materiality with Zero-Waste Knit Innovation

August 25, 2026

LBMC Expands HITRUST Services with Authorized Reseller Status, Giving Clients One Point of Coordination for Certification

August 25, 2026

HdL Companies Welcomes Scott Hardwick, Expanding Deep Municipal and Economic Development Expertise

August 25, 2026

Latest News

Saskatoon reports new cases of Dutch elm disease with removal planned

August 25, 2026

Dolly Parton, country music icon, dead at 80

August 25, 2026

Palmetto Publishing Releases Dr. Robert W. Schultz's New Leadership Guide Success 101

August 25, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version